Inventor · disambiguated record
Yanqin Liu
Also filed as: LIU YANQIN
11 granted patents·9 pending applications·17 citations·filing 2019–2025
82Inventor score
Top patents by PatentIndex Score
20 records- 0186USD972856SPlant standLIU YANQIN·Filed 2022·Granted Dec 20, 2022·17 cites·1 claims
- 0283US12246020B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Granted Mar 11, 2025·0 cites·20 claims
- 0377US2025313545A1Heteroaryl compounds, solid forms, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2025·Application pending·0 cites
- 0474US11865115B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Granted Jan 9, 2024·0 cites·3 claims
- 0572US2024025876A1Heteroaryl compounds, solid forms, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 0671US12391677B2Thyroid hormone receptor agonistsINVENTISBIO CO LTD·Filed 2019·Granted Aug 19, 2025·0 cites·10 claims
- 0770US12173010B2Heterocyclic compounds, preparation methods therefor, and methods of uses thereofINVENTISBIO CO LTD·Filed 2023·Granted Dec 24, 2024·0 cites·19 claims
- 0870US11241437B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Feb 8, 2022·0 cites·23 claims
- 0969US2025340542A1Thyroid hormone receptor agonistsINVENTISBIO CO LTD·Filed 2025·Application pending·0 cites
- 1066US12256737B2Preparation method and application of water-soluble chlorhexidine hyaluronate antibacterial agentsUNIV JIANGNAN·Filed 2024·Granted Mar 25, 2025·0 cites·6 claims
- 1161US12110289B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Oct 8, 2024·0 cites·17 claims
- 1259US2024189313A1Solid dispersionsINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 1358US11691981B2Heterocyclic compounds, preparation methods therefor, and methods of uses thereofINVENTISBIO CO LTD·Filed 2020·Granted Jul 4, 2023·0 cites·21 claims
- 1455US12509448B2Salts of indoleamine 2,3-dioxygenase inhibitorsINVENTISBIO CO LTD·Filed 2020·Granted Dec 30, 2025·0 cites·12 claims
- 1555US2023263782A1Oral formulations and uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
- 1652US2023357233A1Heteroaryl compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
- 1751US2023242544A1Quinazoline compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
- 1851US2023339911A1Pyridazinone compoundsINVENTISBIO CO LTD·Filed 2020·Application pending·0 cites
- 1950US2022213066A1Salts of a class of pyrimidine compounds, polymorphs, and pharmaceutical compositions thereof, preapration methods therefor and uses thereofINVENTISBIO CO LTD·Filed 2020·Application pending·0 cites
- 2048US12427146B2C-terminal SRC kinase inhibitorsINVENTISBIO CO LTD·Filed 2019·Granted Sep 30, 2025·0 cites·38 claims
Join the waitlist — get patent alerts
Get an alert when Yanqin Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →